Tag: cancer vaccines market growth

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

Cancer Vaccines Market: What is the Projected CAGR for 2024-2033?

In the past few years, the size of the cancer vaccines market has seen swift expansion. The market is projected to increase from $7.22 billion in 2023 to $8.25 billion in 2024, achieving a compound annual growth rate (CAGR) of 14.3%. The immense growth during the historic period is due to a combination of factors including a surge in cancer cases, heightened awareness about cancer vaccines, expanding portfolio of approved cancer vaccines, and burgeoning evidence supporting the effectiveness of these vaccines, supplemented by governmental backing for research and development efforts.

The market size of cancer vaccines is projected to experience swift expansion in the upcoming years. The projected growth is estimated to reach a value of $13.89 billion in 2028, with a compound annual growth rate (CAGR) of 13.9%. Factors contributing to the anticipated growth within this period include the integration of cancer vaccines with other therapies, increased funding from pharmaceutical firms, the emergence of biomarkers, customised vaccines, and the expansion of immunization programs. The forecast period also points towards significant trends such as advancements in the field of immunology, auxiliary treatments, diversification of indications, improved access for patients, collaborative studies, neoantigen-focused vaccines, and therapeutic vaccines for cancer.

Claim Your Free Sample of the Global Cancer Vaccines Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

What Are the Primary Drivers Supporting the Growth of the cancer vaccines Market?

The global rise in cancer cases is predicted to enhance the expansion of the cancer vaccines market throughout the forecasted timeline. For example, as per the American Cancer Society’s January 2022 statistics, it is expected that 1.9 million novel cancer cases and 609,360 deaths owing to cancer will occur in the US, which translates to about 1,670 deaths daily. Lung, prostate, bowel, and female breast cancer, which are the four most prevailing cancer types around the globe, make up 43 percent of all new cancer diagnoses. Consequently, this upward trend in global cancer incidence is expected to stimulate the demand for the cancer vaccine market in the next few years.

What Are the Core Segments of the Cancer Vaccines Market?

1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types

4) By End-User: Cancer Treatment Centers, Research Institutes

What Trends Are Paving the Way for Change in the Cancer Vaccines Market?

Investments in preventive, or prophylactic, cancer vaccines are surging within the cancer vaccine industry. These vaccines work to enhance immunity in patients by introducing antigens into their body. Cervical cancer – the second most prevalent cancer in women, as cited by the World Health Organization – makes up 84% of new cancer cases globally. Presently, three HPV vaccines have been developed for the prevention of cancer. Two of these vaccines effectively combat HPV 16 and HPV 18, responsible for 70% of cervical cancer cases. An additional vaccine combats three more oncogenic HPV types responsible for a further 20% of cervical cancer incidences. These vaccines include Merck’s Gardasil and Gardasil 9, and GSK’s Cervarix.

Order Now for Fast Delivery of Your Cancer Vaccines Market Report!

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Which Regions Are Leading the Charge in Cancer Vaccines Market Development?

North America was the largest region in the cancer vaccines market in 2023. The regions covered in the cancer vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The Cancer Vaccines Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cancer vaccines market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Cancer Vaccines Market Include

1. Cancer Vaccines Market Executive Summary

2. Cancer Vaccines Market Segments

3. Cancer Vaccines Market Size And Template Market Growth Rate

4. Key Cancer Vaccines Market Trends

5. Major Cancer Vaccines Market Drivers

……

25. Key Mergers And Acquisitions In The Cancer Vaccines Market

26. Top Cancer Vaccines Companies

27. Cancer Vaccines Market Opportunities And Strategies

28. Cancer Vaccines Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Veterinary Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Therapeutic Proteins Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Vaccine Adjuvants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The cancer vaccines market size has grown rapidly in recent years. It will grow from $7.22 billion in 2023 to $8.25 billion in 2024 at a compound annual growth rate (CAGR) of 14.3%. Let’s delve into the factors fueling this growth and what the forecast holds for the future.

Rising Cancer Cases Drive Demand For Cancer Vaccines

• The rise in cancer cases across the globe contributes to market growth.
• Globally, lung, prostate, bowel, and female breast cancer account for 43% of all new cancer cases.
• The anticipated increase in cancer incidence rates globally boosts the demand for cancer vaccines.
• Major companies operating in the market include GlaxoSmithKline PLC, Merck & Co. Inc., and AstraZeneca PLC.

Quadrivalent Vaccines Gain Traction In The Cancer Vaccines Market

• Major companies focus on introducing quadrivalent vaccines to maximize revenue.
• Serum Institute of India launched CERVAVAC, the first made-in-India cervical cancer vaccine, targeting HPV types responsible for at least 70% of cervical cancers.
• Quadrivalent vaccines are designed to protect against four different strains or types of a specific virus or bacteria.

Read More On The Cancer Vaccines Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

NEC OncoImmunity Strengthens Cancer Therapy Portfolio

• In March 2022, NEC OncoImmunity acquired neoantigen vaccine development assets from Vaximm AG, enhancing its AI-optimized personalized cancer therapies.
• Vaximm AG manufactures vaccines and T-cell immunotherapies for cancer patients.

Segmentation Insights
The cancer vaccines market is segmented by type, technology, cancer type, and end-user:

1. By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
2. By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines
3. By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types
4. By End-User: Cancer Treatment Centers, Research Institutes

North America Leads the Way

• North America dominated the cancer vaccines market in 2023.

Forecasting the Future
The cancer vaccines market is expected to witness significant growth in the next few years. It will reach $13.89 billion in 2028 at a compound annual growth rate (CAGR) of 13.9%. Here’s what drives this forecasted growth:

• Combination therapies with cancer vaccines.
• Increased investment from pharmaceutical companies.
• Emerging biomarkers and personalized vaccines.
• Expanding vaccination programs.

Emerging Trends
The forecast period also brings forth several trends:

• Advancements in immunology and adjuvant therapies.
• Diversification of indications and enhanced patient access.
• Collaborative research initiatives and neoantigen-based vaccines.
• Therapeutic cancer vaccines pave the way for a promising future.

Final Thoughts
The landscape of cancer vaccines is evolving rapidly, driven by advancements in technology, rising cancer cases, and strategic collaborations among key players. As the market continues to expand, innovations in preventive and therapeutic vaccines hold the promise of revolutionizing cancer treatment and prevention globally. The forecasted growth underscores the urgency and importance of continued research and investment in this critical area of healthcare. As we navigate through the complexities of cancer treatment, the development and adoption of vaccines stand as beacons of hope in our collective fight against this formidable disease.

Request for A Sample Of The Global Cancer Vaccines Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=3452&type=smp